Current state of immunotherapy for non-small cell lung cancer

Lung cancer is the leading cause of cancer mortality and non-small cell lung cancer (NSCLC) accounts for more than 85% of all lung cancers. Platinum-based doublet chemotherapy is the standard first-line treatment for metastatic NSCLC when genomic testing reveals no targetable alteration such as epid...

Full description

Saved in:
Bibliographic Details
Published in:Transl Lung Cancer Res
Main Authors: Malhotra, Jyoti, Jabbour, Salma K., Aisner, Joseph
Format: Artigo
Language:Inglês
Published: AME Publishing Company 2017
Subjects:
Review Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5420529/
https://ncbi.nlm.nih.gov/pubmed/28529902
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tlcr.2017.03.01
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items